PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.

Smith, Aaron G

PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells. [electronic resource] - The international journal of biochemistry & cell biology Apr 2009 - 844-52 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1878-5875

10.1016/j.biocel.2008.08.037 doi


Animals
Antineoplastic Agents--pharmacology
COS Cells
Cell Cycle--drug effects
Cell Growth Processes--drug effects
Cell Line, Tumor
Chlorocebus aethiops
Chromans--pharmacology
Halofenate--pharmacology
Humans
Melanoma--drug therapy
PPAR gamma--agonists
RNA, Messenger--biosynthesis
RNA, Small Interfering--genetics
Rosiglitazone
Signal Transduction--drug effects
Thiazolidinediones--pharmacology
Troglitazone
Wnt Proteins--agonists
beta Catenin--genetics